Back to search

Article

Differential PML localization in tumor-associated macrophages reflects the inflammatory state and the prognosis of triple-negative breast cancer patients

2024-12-04

Abstract excerpt

<title>Abstract</title> <p>Background Triple-negative breast cancer (TNBC) stands out as a particularly aggressive and metastatic subtype, defined by its absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. It's important to note that outcomes for TNBC patients vary widely, suggesting this classification encompasses various cancers with different histological, genomi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eaa19b27-68ca-5a4a-9fea-9deee24ddd1b
DOI
10.21203/rs.3.rs-5396306/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Differential PML localization in tumor-associated macrophages reflects the inflammatory state and the prognosis of triple-negative breast cancer patientsDOI 10.21203/rs.3.rs-5396306/v1
Classification of triple-negative breast cancer based on immune cell infiltrationSemantic proximity
Understanding tissue-resident macrophages unlocks the potential for novel combinatorial strategies in breast cancerSemantic proximity
Single-cell Atlas reveals core function of CPVL/MSR1 expressing macrophages in the prognosis of triple-negative breast cancerSemantic proximity
A CTL/M2 Macrophage-Related Four-Gene Signature Predicting Metastasis-Free Survival in Triple-Negative Breast Cancer Treated with Adjuvant RadiotherapySemantic proximity
Spatial-Immune Multi-omics Refines Prognostication in Early-Stage Estrogen Receptor-Positive Breast CancerSemantic proximity
Integration of single-cell and bulk transcriptome analyses unravels a macrophage-based gene signature for prognostication and treatment in triple-negative breast cancerSemantic proximity
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancerSemantic proximity
LCP1 is a potential prognostic biomarker and correlates with immune infiltration in triple negative breast cancerSemantic proximity
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Semantic proximity
New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAPSemantic proximity
PML1-Mediated Feedforward Loop Through PI3K and MAPK Axes Drives Endocrine ResistanceSemantic proximity
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast CancerSemantic proximity
Select a neighboring publication to make it the new centre.